imatinib mesylate has been researched along with Leishmaniasis, Visceral in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duarte, FB; Filho, PA; Filho, TP; Lemes, RP; Moreira-Nunes, CA; Quixada, A | 1 |
1 other study(ies) available for imatinib mesylate and Leishmaniasis, Visceral
| Article | Year |
|---|---|
Pancytopenia during tyrosine kinase inhibitor treatment - coexistence of chronic myeloid leukemia and visceral leishmaniasis: a case report.
Topics: Adult; Humans; Imatinib Mesylate; Leishmaniasis, Visceral; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Pancytopenia; Protein Kinase Inhibitors | 2016 |